Long-Term Clinical Remission in Biologically Naïve Crohn's Disease Patients with Adalimumab Therapy, Including Analyses of Switch from Adalimumab to Infliximab

There is little evidence regarding the maintenance of long-term clinical remission by adalimumab (ADA) therapy in Crohn's disease (CD) patients naïve to anti-tumor necrosis factor treatment (naïve CD patients), since most CD patients are treated with ADA after infliximab (IFX) therapy. The long...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Case Rep Gastroenterol
Main Authors: Mizoshita, Tsutomu, Tanida, Satoshi, Ozeki, Keiji, Katano, Takahito, Shimura, Takaya, Mori, Yoshinori, Kubota, Eiji, Kataoka, Hiromi, Kamiya, Takeshi, Joh, Takashi
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2016
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4939671/
https://ncbi.nlm.nih.gov/pubmed/27462198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000445105
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki